Profile
POAI ISRG BDX BDXA ALC RMD
Company Name Predictive Oncology Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $2.09M $173.36B $59.94B $55.91B $39.26B $37.85B
Employees 0.02K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Raymond F. Vennare David J. Rosa Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell
Ratings
POAI ISRG BDX BDXA ALC RMD
Quant Rating Score 2 1 3 5 3 4
Quant Rating Sell Strong Sell Neutral Strong Buy Neutral Buy
Trading
POAI ISRG BDX BDXA ALC RMD
Last Close $6.08 $546.71 $190.98 $59.24 $76.61 $244.71
High 52 $14.7 $610.45 $249.08 $59.24 $98.3 $293.73
Low 52 $0.64 $429.59 $165.15 $59.24 $72.05 $204.58
Price vs. 52 Week High -58.64 % -10.44 % -23.33 % 0 % -22.07 % -16.69 %
Price vs. 52 Week Low 850 % 27.26 % 15.64 % 0 % 6.33 % 19.62 %
Total Return
POAI ISRG BDX BDXA ALC RMD
1 Month Return -36.23 % 22.54 % 0.99 % 0 % 2 % -8.72 %
3 Month Return 612.61 % 13.64 % -2.06 % 0 % -13.07 % -14.47 %
6 Month Return 462.96 % -3 % 8.88 % 0 % -14.72 % -2.77 %
9 Month Return 211.79 % -9.02 % -15.17 % 0 % -14.35 % 6.13 %
YTD Return 641.46 % 4.74 % -15.82 % 0 % -9.75 % 7.01 %
1 Year Return 844.1 % 1.46 % -14.22 % 0 % -10.32 % 2.77 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
POAI ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.99 % 1.99 % 0.42 % 0.87 %
Dividend Paid and Capex Coverage Ration (TTM) -8775993 % 4.3 % 1.75 % 1.75 % 3.02 % 4.31 %
Dividend Per Share (TTM) - - 4.17 % 4.17 % 0.33 % 2.26 %
Payout Ratio (TTM) - - 71.28 % 71.28 % 15.49 % 22.31 %
Profitability
POAI ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 50.24 % 66.06 % 45.44 % 45.44 % 55.12 % 60.08 %
Return on Assets TTM -2688.13 % 14.76 % 3.03 % 3.03 % 3.32 % 17.31 %
Return on Equity TTM 424.7 % 16.72 % 6.63 % 6.63 % 4.77 % 25.13 %
Return on Capital Employed TTM 13.56 % 16.78 % 5.48 % 5.48 % 5.06 % 24.74 %
Net Income Per EBT TTM 100.38 % 86.25 % 89.16 % 89.16 % 84.1 % 82.6 %
EBT Per Ebit TTM 811.68 % 112.42 % 73 % 73 % 86.34 % 99.79 %
EBIT Per Revenue TTM -1421.38 % 29.27 % 11.8 % 11.8 % 14.16 % 33.18 %
Cash Flow To Debt Ratio TTM -463.89 % - 17.88 % 17.88 % 39.18 % 222.53 %
Receivables Turnover TTM 28 7.27 7.29 7.29 5.26 5.49
Payables Turnover TTM 0.13 11.73 - - 5.11 7.87
Inventory Turnover TTM 9.54 1.92 3.06 3.06 1.88 2.22
Fixed Asset Turnover TTM 38.58 % 195.4 % 312.12 % 312.12 % 198.09 % 724.52 %
Asset Turnover TTM 23.21 % 52.01 % 39.47 % 39.47 % 32.34 % 63.28 %
Operating Cash Flow Per Share TTM -12.12 8.34 11.97 11.97 4.16 12.86
Free Cash Flow Per Share TTM -12.12 6.4 9.32 9.32 3.11 12.06
Cash Per Share TTM 25.09 % 1383.15 % 299.71 % 299.71 % 303.41 % 944.79 %
Operating Cash Flow Sales Ratio TTM -1205.17 % 29.42 % 15.71 % 15.71 % 20.13 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 76.72 % 77.84 % 77.84 % 74.75 % 93.83 %
Cash Flow Coverage Ratios TTM -463.89 % - 17.88 % 17.88 % 39.18 % 222.53 %
Price To Free Cash Flows Ratio TTM -1.11 76.32 22.45 22.41 25.61 21.42
Price To Operating Cash Flows Ratio TTM -0.24 58.52 17.55 17.55 19.09 20.16
Price Cash Flow Ratio TTM -0.24 58.52 17.55 17.55 19.09 20.16
Income Statement (TTM)
POAI ISRG BDX BDXA ALC RMD
Revenue $0B $10.06B $21.84B $21.84B $9.91B $5.15B
Gross Profit $0B $6.64B $9.92B $9.92B $5.51B $3.05B
Gross Profit Ratio 49.12% 66.13% 45.44% 45.44% 55.61% 59.36%
EBITDA $-0.01B $3.62B $4.96B $4.96B $2.68B $1.91B
Net Income $-0.01B $2.86B $1.68B $1.68B $1.02B $1.4B
EPS Diluted -2.24 7.87 5.83 5.83 2.05 9.51
Balance Sheet (MRQ)
POAI ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0.26B $17.62B $17.62B $4.97B $0.81B
Total Liabilities $0.01B $2.69B $29.94B $29.94B $8.79B $2.21B
Total Equity $-0B $17.94B $25.39B $25.39B $21.55B $5.97B
Total Investments $0B $5.87B $0.01B $0.01B $0.91B $0.09B
Total Debt $0B $0.3B $19.18B $19.18B $5.14B $0.85B
Total Assets $0B $20.63B $55.33B $55.33B $30.35B $8.17B
Cash Flow Statement (TTM)
POAI ISRG BDX BDXA ALC RMD
Net Income $-0.01B $2.88B $1.68B $1.68B $1.02B $1.4B
Inventory $0B $-1.06B $-0.41B $-0.41B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.2B $-1.2B $-0.13B $-0.31B
Operating Cash Flow $-0.01B $3.03B $3.43B $3.43B $2.08B $1.75B
Capital Expenditure $-0B $-0.54B $-0.76B $-0.76B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 79.44
ANGO AngioDynamics, Inc. 11.38
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 139.98
ATRC AtriCure, Inc. 32.925
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 9.65
AZTA Azenta, Inc. 30.43
BAX Baxter International Inc. 22.3
BDX Becton, Dickinson and Company 180.61
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 17.04
BLFS BioLife Solutions, Inc. 22.25
COO The Cooper Companies, Inc. 83.02
DXR Daxor Corporation 12.41
EKSO Ekso Bionics Holdings, Inc. 9.9
ETFs With Exposure to POAI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 341.49
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.485
VXF Vanguard Extended Market Index Fund 0.00003 218.255
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000926 41.315
VTSAX Vanguard Total Stock Market Index Fund 0 166.35
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 166.39
VITSX Vanguard Total Stock Market Index Fund 0 166.38
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 166.41
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 410.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 312.11
Unlock